Zim Laboratories, Athena Drug Delivery Solutions, Aizant Drug Research Solutions, Pharmaffiliates Analytics and Synthetics, Srushti Pharmaceuticals, Murli Krishna Pharma shortlisted for top six finalists for the coveted “Pharma Leaders Most Promising & Innovative company in Drug Delivery Solutions 2018”
Zim Laboratories, Athena Drug Delivery Solutions, Aizant Drug Research Solutions, Pharmaffiliates Analytics and Synthetics, Srushti Pharmaceuticals, Murli Krishna Pharma shortlisted for top six finalists for the coveted “Pharma Leaders Most Promising & Innovative company in Drug Delivery Solutions 2018”
Pharma Leaders Most Promising & Innovative company in Drug Delivery Solutions 2018 Nominees
1.Zim Laboratories Limited.
2.Athena Drug Delivery Solutions Pvt. Ltd.
3.Aizant Drug Research Solutions Private Limited.
4.Pharmaffiliates Analytics and Synthetics(P) Ltd
5.Srushti Pharmaceuticals Pvt. Ltd.
6.Murli Krishna Pharma Pvt Ltd.
Voting Link : https://goo.gl/forms/PaQgsCd5SSlZDAC02
A Drug Delivery System (DDS) can help improve drug absorption, extend the effective lifetime of a drug in the body, and deliver the drug specifically to the affected area. A DDS can thus maximize the effect of drugs.
Examples include prodrugs developed for improving drug solubility, absorbability and retention. In addition, macromolecular carriers have been actively investigated to deliver or target drugs to the affected area.
India’s drug delivery devices market is expected to reach USD 20 billion by the end of 2020. Currently, North America dominates the global market owing to the fact that there is greater awareness and increase per capita income. The Asia-Pacific region is expected to show good growth in the future, primarily due to the increased awareness among the population. The APAC market is expected to dominate the market in the future and overtake Europe.
Shrinking number of new innovative drugs and increasing number of blockbuster medicines going off-patent, is driving the growth of niche segments such as novel drug discovery systems (NDDS), and at the same time, becoming a big opportunity for pharma majors.
It is estimated that NDDS products constitute 17% of the world’s pharma market, $104 billion. Similar trends are visible in India, with NDDS products representing nearly 6% of the domestic market.
The pharmaceutical business is growing at a phenomenal rate with novel drug delivery systems being the cardinal driver for the conspicuous upsurge. Novel drug delivery systems offer superior therapeutic potential by addressing market and/or patient needs and offer patient compliance through enhanced efficacy, reduced dose/dosing frequency, decreased toxicity, and ease of administration. In view of these advantages, the growth of these innovative drug delivery systems is also boosted by fast track approvals from regulatory authorities to ensure their rapid entry into the market.
At present, NDDS products’ revenues is nearly Rs 1500 crore, with an annual growth of 29% – well ahead of the industry’s growth rate at 17% per annum. Novel Drug Delivery Systems (NDDS) is a new drug delivery technology which improves patient compliance, raise the drugs pharmacokinetic (absorption, distribution and metabolism) profile, reduce the dosage frequency or adverse side-effects, and combine therapeutically complementary drugs in one formulation.
In a way, if the patient was earlier consuming a drug three-four times a day, he/she now, thanks to NDDS, needs to take the same medicine only once or twice daily. NDDS has become very popular in patients suffering from chronic diseases such as Aids and cancer.
For patients, it means more safety, efficacy and a better compliance. While for drug companies, product innovations in the form NDDS is a big opportunity to rejuvenate their brands by making products easier to administer, more patient-friendly and ultimately more effective, and at the same time, augment their revenues.
Ranked by Industry experts, Pharma Leaders is arguably the India’s largest & most trusted healthcare communication company specializing in executing high profile research findings, media broadcasting, healthcare campaigning & producing highly acclaimed world-class events once in a year .We are one of the very few global healthcare company with leadership positions in reaching out to the key sectors & stakeholders of pharmaceutical and life sciences, healthcare firms, hospitals, medical services, top notch opinion makers in the medical profession & other disciplines associated with healthcare industry. Pharma Leaders research findings are often cited at various credible places & the annual awards are most awaited prestigious, coveted & credible healthcare leadership awards conferred to the trendsetters & path-breaking companies. Unlike other companies, Pharma Leaders refuses to follow the traditional approach in reaching out to the final rankings based on false & ambiguous reports which deny the high performing companies, though small but rich in innovative practices & often ignored by the mainstream media & lost out to the biggies. The robust selection process at Pharma Leaders awards are a year long process where only innovations & out of box ideas triumph.